, seizure clusters, acute repetitive seizures) which have been distinct from a affected person’s usual seizure sample in individuals between two and five years of age and beating the orphan drug market place exclusivity of the FDA accredited nasal spray solution of another organization extending to January 2027; concerning the probable benefits L